Aaron Sverdlov

Has grant

Professor in Cardiology/Director of Heart Failure

Newcastle University

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Aaron Sverdlov is a Professor in Cardiology and the Director of Heart Failure at the University of Newcastle, Australia. His research primarily focuses on the implementation of cardiac devices, remote patient monitoring, and the effects of cancer treatments on cardiovascular health. Recent publications include studies on neurohormonal blockers, cardiotoxicity, and innovative biomarkers in cardiovascular disease.

Recent Grants

Grant: Close

Bench-to-bedside approach to improving management and outcomes for patients with heart failure

Open Date: 2018-01-01

Close Date: 2021-12-01

Grant: Close

Beetroot supplementation and exercise tolerance: another way to boost physical activity to combat obesity?

Open Date: 2016-01-01

Close Date: 2017-12-01

Grant: Close

Oxidative posttranslational modifications of mitochondrial complex II in metabolic heart disease

Open Date: 2014-07-01

Close Date: 2015-04-01

Grant: Close

Do fatty acids poison the heart s energy generation?

Open Date: 2012-01-01

Close Date: 2017-12-31

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Andrew Sindone

Clinical Associate Professor

The University of Sydney Sydney University Press

AUSTRALIA

View details

Doan T. M. Ngo

Newcastle University

AUSTRALIA

View details

Bogda Koczwara

Flinders University

AUSTRALIA

View details

Andrew J. Maiorana

Curtin University

AUSTRALIA

View details

Heather Lee

University of Newcastle Australia

AUSTRALIA

View details

Clara Chow

Professor of Medicine, Academic Director, WARC

University of Sydney

AUSTRALIA

View details

Andrea Driscoll

MONASH UNIVERSITY

AUSTRALIA

View details

Linda Denehy

University of Melbourne

AUSTRALIA

View details

Amanda Croft

University of Newcastle Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aaron Sverdlov

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (26)

Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities: transcriptomic and epigenetic profiling.

Barriers and Enablers to Routine Clinical Implementation of Cardiac Implantable Electronic Device Remote Monitoring in Australia Among Cardiologists, Cardiac Physiologists, Nurses, and Patients: Interview Study

Factors influencing the adoption of Internet of Medical Things for remote patient monitoring: A systematic literature review

The SARAH trial: more evidence on the role of neurohormonal blockers in prevention of anthracycline-induced cardiotoxicity.

Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score

A retrospective analysis of cardiovascular outcomes of clozapine treated individuals within Hunter New England.

Novel Biomarkers of Cerebrovascular Function in Adult Congenital Heart Disease

2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF

Optimising Transitional Care Following a Heart Failure Hospitalisation in Australia

How to build an actionable narrative for cardio-oncology

Cancer Therapies and Cardiomyocyte Viability: Which Drugs are Directly Cardiotoxic?

Women's cardiovascular health - the cardio-oncologic jigsaw

Demographics and Health Characteristics Associated With the Likelihood of Participating in Digitally Delivered Exercise Rehabilitation for Improving Heart Health Among Breast Cancer Survivors: Cross-Sectional Survey Study

Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial.

When Cancer and Cardiovascular Disease Intersect

Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function

Overexpression of Mitochondrial Catalase within Adipose Tissue Does Not Confer Systemic Metabolic Protection against Diet-Induced Obesity

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)

Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation

Cardiovascular outcomes of cancer patients in rural Australia

Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation

Remote monitoring in patients with heart failure with cardiac implantable electronic devices: a systematic review and meta-analysis

International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL

Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation

Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab

Pulmonary Hypertension Due to Left Heart Disease

Collaborators (9)

Andrew Sindone

Doan T. M. Ngo

Bogda Koczwara

Andrew J. Maiorana

Heather Lee

Clara Chow

Andrea Driscoll

Linda Denehy

Amanda Croft

Make your next move.